Phase I Dose Escalation Study of HBI-8000 in Combination with Paclitaxel and Trastuzumab in Women with Advanced or Metastatic HER2+ Solid Tumors
|Effective start/end date||2/1/16 → 4/13/17|
- HUYA BIOSCIENCE INTERNATIONAL, LLC
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.